Cardiovascular disease and cancer are the 2 leading causes of death worldwide. Emerging
evidence suggests common mechanisms between cancer and cardiovascular disease …

Background A growing body of evidence suggests that atrial fibrillation (AF) is associated
with myocardial infarction (MI). However, incidence and management of MI in AF is still …

Background Gut microbiota is emerging as a novel risk factor for atherothrombosis, but the
predictive role of gut‐derived lipopolysaccharide (LPS) is unknown. We analyzed (1) the …

Prostaglandins (PGD2, PGE2, PGF2α), prostacyclin (PGI2), and thromboxane A2 (TXA2)
together form the prostanoid family of lipid mediators. As autacoids, these five primary …

Background: Soluble proprotein convertase subtilisin/kexin type 9 (PCSK9) has been shown
to be predictive of cardiovascular events (CVEs) in patients who are at high cardiovascular …

Background Immune activation persists despite suppressive antiretroviral therapy (ART) in
human immunodeficiency virus (HIV) infection and predicts non-Acquired Immune …

Statins are effective for reducing cardiovascular disease in patients at risk or with
cardiovascular disease. The benefit of statin therapy on adverse cardiovascular outcomes in …

Risk assessments are an important element in the management of patients with atrial
fibrillation (AF). In this review, we aim to discuss the concepts and controversies surrounding …

Background Experimental studies demonstrated that glutathione peroxidase 3 (GP x3), an
antioxidant enzyme that catabolizes hydrogen peroxide, protects against thrombosis. Little is …

Objective To determine the impact of preexisting diabetes mellitus on cardiovascular and all-
cause mortality in patients with atrial fibrillation (AF) by conducting a meta-analysis. Methods …